This is an observational study designed to follow patients with RA who have had an inadequate response to one or more anti-TNF therapies and who will receive Rituxan. Approximately 1000 patients in the United States with RA who have had an inadequate response to anti-TNF therapies and who will receive Rituxan therapy will be recruited. There is no protocol mandated treatment assignment in this study. Patients will be evaluated and treated according to their physician's standard practice and discretion.
Study Type
OBSERVATIONAL
Enrollment
1,026
Rheumatology Associates, PC
Birmingham, Alabama, United States
Rheumatology Associates of N. AL, P.C.
Huntsville, Alabama, United States
Clinic for Rheumatic Diseases - Research Department
Tuscaloosa, Alabama, United States
Arizona Arthritis and Rheumatology Research, PLLC
Paradise Valley, Arizona, United States
Phoenix Rheumatology Specialists, Ltd.
Phoenix, Arizona, United States
Advanced Arthritis Care & Research
Scottsdale, Arizona, United States
The Arthritis Center of the Ozarks
Fayetteville, Arkansas, United States
Investigational Site
Covina, California, United States
Arthritis Medical Clinic of North County, Inc.
Escondido, California, United States
Solano Regional Medical Group
Fairfield, California, United States
...and 183 more locations
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.